March 12, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global Innovators 2025. This marks the 12th consecutive year Philips has been included in this assessment.
“At Philips, we’ve been innovating for over 130 years to improve people’s lives,” said Roy Jakobs, CEO of Royal Philips. “Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI and services drives healthcare productivity and empowers people to look after their health and well-being – delivering better care for more people.”
In 2024, the company invested approximately EUR 1.7 billion, or an industry-leading >9% of sales, in research and development. Philips is increasingly focused on the potential of data and AI, dedicating around half of its R&D workforce to these fields, and leading in AI-related patent applications in healthcare. A few of Philips’ AI-powered innovations include:
- The Philips CT 5300, which uses a combination of hardware, software, and AI to make high-quality screening, diagnostic, and interventional imaging accessible to more patients.
- The latest SmartSpeed Precise MRI technology, which enables scans to be completed up to three times faster.
- The next-generation AI-enabled cardiovascular ultrasound platform with advanced AI tools to advance cardiovascular imaging.
- The new Azurion image-guided therapy system and advanced informatics for minimally invasive diagnosis and treatment of stroke and other neurovascular patients.
The Top 100 Global Innovators assessment uses data to evaluate the strength of every patented idea, using measures tied directly to their innovative power.
Visit the full report from Clarivate
For further information, please contact:
Ben Zwirs Philips Global External Relations Tel.: +31 61521 3446 E-mail: media@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips leverages advanced technology and clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
